FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605856369> ?p ?o ?g. }

• W2605856369 endingPage "358" @default.
• W2605856369 startingPage "355" @default.
• W2605856369 abstract "Purpose of review Reduced dose efavirenz, dolutegravir, and/or tenofovir alafenamide (TAF) are likely to be used in the next generation of first-line antiretroviral therapy in resource limited settings, where HIV-associated tuberculosis is common. Rifampicin, which is a key component of first-line antituberculosis therapy, is a potent inducer of many drug transporters and metabolising enzymes. We reviewed the literature for potential or actual drug--drug interactions between these antiretrovirals and rifampicin. Recent findings Dose adjustments of standard dose efavirenz are not necessary with rifampicin, because auto-induction of CYP2B6 by efavirenz counteracts the induction of rifampicin. However, patients with extensive metabolizer CYP2B6 genotypes have lower efavirenz concentrations and may have less auto-induction of CYP2B6; the additive inducing effects of rifampicin on CYP2B6 could result in clinically significant reductions of efavirenz concentrations. Doubling the dose of dolutegravir overcomes induction by rifampicin. TAF is more prone to be the victim in drug--drug interactions than tenofovir disoproxil fumarate. Interactions between TAF and rifampicin have not been studied, but there is likely to be significant interaction. Summary Further research on drug--drug interactions between rifampicin and the next generation of first-line antiretrovirals will be needed before they can be recommended in patients with HIV-associated tuberculosis." @default.
• W2605856369 created "2017-04-28" @default.
• W2605856369 creator A5007876312 @default.
• W2605856369 creator A5017420608 @default.
• W2605856369 creator A5034322602 @default.
• W2605856369 date "2017-07-01" @default.
• W2605856369 modified "2023-10-10" @default.
• W2605856369 title "Compatibility of next-generation first-line antiretrovirals with rifampicin-based antituberculosis therapy in resource limited settings" @default.
• W2605856369 cites W1653851471 @default.
• W2605856369 cites W1773899404 @default.
• W2605856369 cites W1910280141 @default.
• W2605856369 cites W1931334913 @default.
• W2605856369 cites W1963753263 @default.
• W2605856369 cites W1970755954 @default.
• W2605856369 cites W1977324053 @default.
• W2605856369 cites W1983688597 @default.
• W2605856369 cites W2007391846 @default.
• W2605856369 cites W2011030044 @default.
• W2605856369 cites W2036234686 @default.
• W2605856369 cites W2050781209 @default.
• W2605856369 cites W2056565974 @default.
• W2605856369 cites W2090261939 @default.
• W2605856369 cites W2101283184 @default.
• W2605856369 cites W2105634155 @default.
• W2605856369 cites W2109499383 @default.
• W2605856369 cites W2144905510 @default.
• W2605856369 cites W2149185709 @default.
• W2605856369 cites W2196612948 @default.
• W2605856369 cites W2345871675 @default.
• W2605856369 cites W2554692247 @default.
• W2605856369 doi "https://doi.org/10.1097/coh.0000000000000376" @default.
• W2605856369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28403028" @default.
• W2605856369 hasPublicationYear "2017" @default.
• W2605856369 type Work @default.
• W2605856369 sameAs 2605856369 @default.
• W2605856369 citedByCount "27" @default.
• W2605856369 countsByYear W26058563692017 @default.
• W2605856369 countsByYear W26058563692018 @default.
• W2605856369 countsByYear W26058563692019 @default.
• W2605856369 countsByYear W26058563692020 @default.
• W2605856369 countsByYear W26058563692021 @default.
• W2605856369 countsByYear W26058563692022 @default.
• W2605856369 countsByYear W26058563692023 @default.
• W2605856369 crossrefType "journal-article" @default.
• W2605856369 hasAuthorship W2605856369A5007876312 @default.
• W2605856369 hasAuthorship W2605856369A5017420608 @default.
• W2605856369 hasAuthorship W2605856369A5034322602 @default.
• W2605856369 hasConcept C109650736 @default.
• W2605856369 hasConcept C126322002 @default.
• W2605856369 hasConcept C142462285 @default.
• W2605856369 hasConcept C142724271 @default.
• W2605856369 hasConcept C159047783 @default.
• W2605856369 hasConcept C2777068322 @default.
• W2605856369 hasConcept C2778607973 @default.
• W2605856369 hasConcept C2779502633 @default.
• W2605856369 hasConcept C2780035454 @default.
• W2605856369 hasConcept C2781069245 @default.
• W2605856369 hasConcept C2781432083 @default.
• W2605856369 hasConcept C2911190787 @default.
• W2605856369 hasConcept C2993143319 @default.
• W2605856369 hasConcept C3013748606 @default.
• W2605856369 hasConcept C50605568 @default.
• W2605856369 hasConcept C526171541 @default.
• W2605856369 hasConcept C62231903 @default.
• W2605856369 hasConcept C71924100 @default.
• W2605856369 hasConcept C98274493 @default.
• W2605856369 hasConceptScore W2605856369C109650736 @default.
• W2605856369 hasConceptScore W2605856369C126322002 @default.
• W2605856369 hasConceptScore W2605856369C142462285 @default.
• W2605856369 hasConceptScore W2605856369C142724271 @default.
• W2605856369 hasConceptScore W2605856369C159047783 @default.
• W2605856369 hasConceptScore W2605856369C2777068322 @default.
• W2605856369 hasConceptScore W2605856369C2778607973 @default.
• W2605856369 hasConceptScore W2605856369C2779502633 @default.
• W2605856369 hasConceptScore W2605856369C2780035454 @default.
• W2605856369 hasConceptScore W2605856369C2781069245 @default.
• W2605856369 hasConceptScore W2605856369C2781432083 @default.
• W2605856369 hasConceptScore W2605856369C2911190787 @default.
• W2605856369 hasConceptScore W2605856369C2993143319 @default.
• W2605856369 hasConceptScore W2605856369C3013748606 @default.
• W2605856369 hasConceptScore W2605856369C50605568 @default.
• W2605856369 hasConceptScore W2605856369C526171541 @default.
• W2605856369 hasConceptScore W2605856369C62231903 @default.
• W2605856369 hasConceptScore W2605856369C71924100 @default.
• W2605856369 hasConceptScore W2605856369C98274493 @default.
• W2605856369 hasIssue "4" @default.
• W2605856369 hasLocation W26058563691 @default.
• W2605856369 hasOpenAccess W2605856369 @default.
• W2605856369 hasPrimaryLocation W26058563691 @default.
• W2605856369 hasRelatedWork W1790877993 @default.
• W2605856369 hasRelatedWork W2000034190 @default.
• W2605856369 hasRelatedWork W2094303174 @default.
• W2605856369 hasRelatedWork W2217095880 @default.
• W2605856369 hasRelatedWork W2278758730 @default.
• W2605856369 hasRelatedWork W2474869173 @default.
• W2605856369 hasRelatedWork W2914093604 @default.
• W2605856369 hasRelatedWork W2942276455 @default.
• W2605856369 hasRelatedWork W3023257405 @default.

• next